ERBB2 and neoplasm: Mice with orthotopic PDTXs from a grade-3 EEC were also treated with paclitaxel or trastuzumab (HER2 inhibitor), and although none inhibited tumor development, EpCAM-NIRF was capable of successfully monitoring uterine tumors.